SBI Healthcare Opportunities Fund - Dividend - Regular Plan

  • Previous Nav

  • Net Change on 13-12-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND 2.83 4.70 -1.21 -4.86 -0.33 14.27
S&P BSE Health Care N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
S&P BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN - DIVIDEND Jul 03, 1999 Unrated -1.21 -4.86 -0.33 2.34 944.05
Nippon India Pharma Fund-Dividend-Dividend Jun 05, 2004 Unrated -0.50 1.73 3.61 2.13 2,434.45
UTI Healthcare Fund - Regular Plan - Income Option Aug 25, 1999 Unrated 1.14 -2.08 -0.21 2.52 400.93

Fund Holdings as on 30-November-2019

  • Sun Pharmaceutical Industries Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Lupin Ltd.

  • Alkem Laboratories Ltd.

  • Abbott India Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Strides Pharma Science Ltd.

  • Alembic Pharmaceuticals Ltd.

  • TREPS

  • Ajanta Pharma Ltd.

  • Sanofi India Ltd.

  • Pfizer Ltd.

  • Aster DM Healthcare Ltd.

  • IPCA Laboratories Ltd.

  • Gufic Biosciences Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Alembic Ltd.

  • Sequent Scientific Ltd.

  • Solara Active Pharma Sciences Ltd.

  • Shreno Ltd.

  • Natco Pharma Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹944.05 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended up ₹0.34(0.45%)yesterday to ₹74.23.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., Cipla Ltd. and Divi's Laboratories Ltd.

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund

Most Recent Dividend

  • 16/03/2018

  • 30/01/2015

  • 04/01/2005

  • 06/09/2004

  • 22/09/2003

  • Cash

  • Equity

  • Preference Shares

View More